DYE-free, on-demand visualization of blood flow during cerebrovascular surgery
Ended Project Grant Awarded Last action
- Award ID
- R44NS124442
- Recipient
-
Vasoptic Medical, Inc. UEI FKB6UR5M6C84
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,664,528
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Originally
- Funding
-
- $2,934,193.26 Federal
- $730,335.00 Non-federal
- Place of performance
- Maryland, USA
Award details come from USAspending.gov.
Description
- Abstract
- Cerebrovascular surgeons performing delicate surgeries such as aneurysm clipping, arteriovenous malformation resections, or revascularization procedures could benefit if quantitative information pertaining to the blood flow status of vessels in their surgical field was made available to them. Current technologies that can monitor blood flow at high resolution either use complex dedicated equipment or rely on administration of contrast agents, both of which are disruptive to the surgical procedure and hence, undesired. DYE-based techniques like ICG video- angiography may not be used frequently and often used only for post-surgical confirmation of surgical success. We propose a novel method that can noninvasively provide real-time information about blood flow in the neurosurgeon's field of view at the spatial scale of microvessels. This modular optical imaging system (called the cvsurgeontm) will integrate with existing neurosurgical microscopes in operating rooms providing the neurosurgeon-user an on-demand video feed of blood flow information to assist in surgical decision-making. This complementary blood flow information will be obtained using proprietary and licensed laser speckle contrast imaging technology, and optionally presented to the neurosurgeon in his/her visual field overlaid on the region of interest. We have previously built a prototype of the system and validated its function in small and large animal models of reversible and irreversible occlusion of vessels in the brain. Our proposed phase II project aims to adapt our technology for clinical use in neurosurgery and then conduct first-in-human studies to validate the system performance and usefulness in three important types of cerebrovascular surgeries - aneurysm clipping, cauterization of arteriovenous malformations, and cerebrovascular bypass surgery for moyamoya disease.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$139,803 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $882,991 | $0 | |
| Amendment | $730,335 | $0 | |
| Amendment | $730,335 | $730,335 | |
| Original award | $730,335 | $0 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| The Johns Hopkins University | $137,431 |
Quick answers
Who received award R44NS124442?
R44NS124442 was awarded to Vasoptic Medical, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on April 1, 2022.
How much is award R44NS124442 worth?
$3,664,528 has been obligated on R44NS124442: $2,934,193 in federal funding and $730,335 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award